Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what ... In March, the weight loss drug Wegovy was FDA-approved to prevent strokes and heart ...
The Food and Drug Administration approved Eli Lilly’s ... the condition by reducing body weight, according to the FDA. The move comes as weight-loss medications have garnered immense national ...
The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.
which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health condition, in November 2023. Although the new FDA green light doesn’t expand the ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec ... “Zepbound promotes weight loss and has been shown to reduce apnea ...
The FDA also recommends that ... Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep ...